Company Filing History:
Years Active: 2014
Title: Frédéric Dargelas: Innovator in Pharmaceutical Technology
Introduction
Frédéric Dargelas is a notable inventor based in Pessac, France. He has made significant contributions to the field of pharmaceutical technology, particularly in the development of oral pharmaceutical forms designed to prevent misuse.
Latest Patents
Dargelas holds a patent for an innovative invention titled "Anti-misuse microparticulate oral pharmaceutical form." This invention relates to solid microparticulate oral pharmaceutical forms whose composition and structure are specifically designed to avoid misuse of the pharmaceutical active principle they contain. The solid oral pharmaceutical form is characterized by the inclusion of anti-misuse means, where at least part of the active principle is contained in coated microparticles. These microparticles are engineered for modified release of the active principle and feature a coating layer that ensures both modified release and crushing resistance, thereby preventing misuse.
Career Highlights
Throughout his career, Frédéric Dargelas has worked with several companies, including Flamel Technologies and Flamel Ireland Limited. His work in these organizations has contributed to advancements in pharmaceutical formulations and drug delivery systems.
Collaborations
Dargelas has collaborated with notable professionals in the field, including Florence Guimberteau and Catherine Castan. These collaborations have further enriched his research and development efforts.
Conclusion
Frédéric Dargelas is a distinguished inventor whose work in pharmaceutical technology has led to innovative solutions aimed at preventing misuse of medications. His contributions continue to impact the industry positively.